How many patents does
Harvard University have?
patents
26,500
families
5,350
granted
4,988
applications
21,512
US
8,501
WO
5,525
EP
4,051
JP
1,482
CN
1,156
KR
476
GB
103
RoW
5,206
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Harvard University
Top ten assignees appearing on patents
2009 - 2018
2018
| novartis | 19 |
| canon u.s.a. | 16 |
| bayer pharma | 13 |
| siemens healthcare | 10 |
| bayer | 8 |
| genzyme corporation | 7 |
| g1 therapeutics | 7 |
| biotheranostics | 6 |
| gpb scientific | 5 |
| ucb biopharma | 5 |
Harvard University
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods, systems, and apparatus for identifying target sequences for cas enzymes or cris… 🛈 | 211 | 2012 |
| nicotine immunonanotherapeutics | 83 | 2007 |
| compositions and methods for modulating metabolism | 80 | 2010 |
| delivery, engineering and optimization of tandem guide systems, methods and compositions… 🛈 | 70 | 2013 |
| methods and compositions for the treatment of persistent infections and cancer by inhibi… 🛈 | 61 | 2005 |
| therapeutic modulation of ocular surface lubrication | 57 | 2008 |
| using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome edi… 🛈 | 51 | 2013 |
| methods of treating multiple myeloma using combination therapies based on anti-cs1 antib… 🛈 | 51 | 2006 |
| highly active anti-neoplastic and anti-proliferative agents | 50 | 2013 |
| process and apparatus for a wavelength tuning source | 49 | 2003 |